PRESS RELEASE
STADA Pymepharco appoints Mr. Ankur Pandey as General Manager,
reinforcing sustainable growth strategy in Vietnam
Ho Chi Minh City, April 2026 – STADA Pymepharco, one of Vietnam’s leading pharmaceutical manufacturers and the wholly owned affiliate of STADA Group (Germany) in Vietnam since 2021, announced the appointment of Mr. Ankur Pandey as General Manager – Vietnam, and as a member of STADA Emerging Markets Leadership Team – effective April 6, 2026.
This appointment represents a strategic step in STADA Pymepharco’s long-term development agenda in Vietnam, aimed at further strengthening its market position, driving sustainable growth, and expanding access to high-quality healthcare solutions aligned with German quality standards.
Building on a Strong Foundation for the Next Phase of Growth
Mr. Pandey brings more than 18 years of experience in the pharmaceutical and healthcare sector across international markets, with a strong track record in Southeast Asia.
Prior to joining STADA Pymepharco, he served as Vice President – Healthcare at DKSH Vietnam. He also held other senior leadership roles within DKSH in Myanmar and Singapore, where he was responsible for business strategy, commercial performance, and operational management.
He has over a decade of experience in P&L leadership within multinational organizations, managing large teams and delivering business growth, organizational transformation, and market expansion across the region.
Mr. Pandey holds a Bachelor’s degree in Pharmacy and an MBA in Pharmaceutical Management from SIES College of Management Studies.
Commenting on his appointment, Mr. Pandey shared: “Throughout my career, collaboration, agility, and entrepreneurship have been my guiding principles as a leader, and I will continue to uphold these values in this new role. I look forward to concluding with the team a transformative journey in the most dynamic markets in Southeast Asia”.
Strengthening Commitment to Vietnam’s Healthcare Sector
In recent years, STADA Pymepharco has continued to reinforce its role in Vietnam’s pharmaceutical industry through professional collaborations, medical education initiatives, and capacity-building programs for pharmacists and healthcare professionals nationwide. The appointment of Mr. Ankur Pandey is expected to further strengthen these efforts and support the company’s next phase of growth.
Delivering Long-Term Value to the Community
The appointment marks an important milestone in STADA Pymepharco’s journey, reaffirming its commitment to sustainable business growth alongside social responsibility, continuous innovation in management, and adherence to international quality standards.
Through this strategic direction, STADA Pymepharco continues to advance its mission of being a trusted partner in community healthcare, while contributing positively to the development of Vietnam’s pharmaceutical sector in the years ahead.
STADA Pymepharco, formerly known as Pymepharco, founded in 1989. STADA Pymepharco has been the wholly affiliate of STADA Group in Vietnam since 2021– a global pharmaceutical group with a 131-year history. 02 EU-GMP certified manufacturing plants located in Tuy Hoa City, Dak Lak Province (formerly Phu Yen) Annual production capacity of each plant reaches 1.2 – 1.4 billion units per shift, along with 20 – 40 million finished packaging units 1,000 employees nationwide 27,000 SKUs, including over 8,000 Consumer Healthcare (CHC) products – developed from approximately 800 active pharmaceutical ingredients (APIs – Active Pharmaceutical Ingredients) 400 SKUs in Vietnam – including approximately 250 generic prescription medicines (Rx) and 150 Consumer Healthcare products, of which around 80 have demonstrated bioequivalence to originator drugs Trusted by 14,000+ customers and partners, including hospitals, medical facilities, pharmacies, pharmacy chains and other pharmaceutical businesses.
|
For further media inquiries, please contact: Public Affairs & Communications Department – STADA Pymepharco Hoang Le Thanh An (Ms.) – Public Affairs and Communications Manager |